The UNMC Eppley Cancer Center provides a controlled access Animal Care Shared Resource that supports the research of UNMC Eppley Cancer Center investigators. The facility has a controlled environment with stable temperatures and humidity. It operates as a type IV barrier system, which reduces both the risks of the introduction of diseases into the Animal Care Shared Resource and their spread should they be introduced. The benefits of the barrier system, controlled access and the minimization of disease introduction and spread, has allowed us to establish two units (embryonal stem cell/gene knockout and transgenic mice). The barrier facility also allows completion of the long-term animal experiments carried out by Cancer Center members. All animals coming into UNMC from non-approved sources such as other investigators at other universities must be housed in a quarantine facility before entering the Cancer Center Shared Resource. They are housed there until the Comparative Medicine staff has determined that the animals are free of pathogenic organisms. Priority for use of the Animal Care Shared Resource is given to Cancer Center members. Use of the Animal Care Shared Resource is contingent upon the activities being consistent with Animal Care Shared Resource policies and the maintenance of the barrier system.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA036727-20
Application #
6998282
Study Section
Subcommittee G - Education (NCI)
Project Start
2004-09-20
Project End
2009-07-31
Budget Start
2004-09-20
Budget End
2005-07-31
Support Year
20
Fiscal Year
2004
Total Cost
$61,950
Indirect Cost
Name
University of Nebraska Medical Center
Department
Type
DUNS #
168559177
City
Omaha
State
NE
Country
United States
Zip Code
68198
Cserhati, Matyas F; Mooter, Mary-Ellen; Peterson, Lauren et al. (2018) Motifome comparison between modern human, Neanderthal and Denisovan. BMC Genomics 19:472
Barkeer, Srikanth; Chugh, Seema; Karmakar, Saswati et al. (2018) Novel role of O-glycosyltransferases GALNT3 and B3GNT3 in the self-renewal of pancreatic cancer stem cells. BMC Cancer 18:1157
Luan, Haitao; Mohapatra, Bhopal; Bielecki, Timothy A et al. (2018) Loss of the Nuclear Pool of Ubiquitin Ligase CHIP/STUB1 in Breast Cancer Unleashes the MZF1-Cathepsin Pro-oncogenic Program. Cancer Res 78:2524-2535
Napon, Geoffroy; Dafferner, Alicia J; Saxena, Ashima et al. (2018) Identification of Carboxylesterase, Butyrylcholinesterase, Acetylcholinesterase, Paraoxonase, and Albumin Pseudoesterase in Guinea Pig Plasma through Nondenaturing Gel Electrophoresis. Comp Med 68:367-374
Azadmanesh, Jahaun; Borgstahl, Gloria E O (2018) A Review of the Catalytic Mechanism of Human Manganese Superoxide Dismutase. Antioxidants (Basel) 7:
Rana, Sandeep; Sonawane, Yogesh A; Taylor, Margaret A et al. (2018) Synthesis of aminopyrazole analogs and their evaluation as CDK inhibitors for cancer therapy. Bioorg Med Chem Lett 28:3736-3740
Chhonker, Yashpal S; Haney, Staci L; Matthiesen, Robert A et al. (2018) Quantitative determination of a potent geranylgeranyl diphosphate synthase inhibitor using LC-MS/MS: Derivatization and application. J Pharm Biomed Anal 153:22-28
Haney, Staci L; Chhonker, Yashpal S; Varney, Michelle L et al. (2018) Preclinical investigation of a potent geranylgeranyl diphosphate synthase inhibitor. Invest New Drugs 36:810-818
Saxena, Sugandha; Hayashi, Yuri; Wu, Lingyun et al. (2018) Pathological and functional significance of Semaphorin-5A in pancreatic cancer progression and metastasis. Oncotarget 9:5931-5943
Lockridge, Oksana; David, Emilie; Schopfer, Lawrence M et al. (2018) Purification of recombinant human butyrylcholinesterase on Hupresin®. J Chromatogr B Analyt Technol Biomed Life Sci 1102-1103:109-115

Showing the most recent 10 out of 1372 publications